PXMD Insider Trading

Insider Ownership Percentage: 57.90%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $279,766.81

PaxMedica Insider Trading History Chart

This chart shows the insider buying and selling history at PaxMedica by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

PaxMedica Share Price & Price History

Current Price: $0.63
Price Change: +0.30 (1.20%)
As of 03/1/2024 12:28 PM ET

This chart shows the closing price history over time for PXMD up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

PaxMedica Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/29/2024Howard J WeismanCEOSell372$0.47$174.8437,675View SEC Filing Icon  
1/29/2024Karen LarochelleDirectorSell78$0.48$37.442,829View SEC Filing Icon  
11/27/2023Howard J WeismanCEOSell162$1.03$166.8638,047View SEC Filing Icon  
11/27/2023John F CoelhoDirectorSell12$1.02$12.244,642View SEC Filing Icon  
11/27/2023Michael DerbyMajor ShareholderSell185$1.03$190.5525,650View SEC Filing Icon  
10/27/2023Howard J WeismanCEOSell473$3.23$1,527.7938,208View SEC Filing Icon  
10/27/2023Michael DerbyMajor ShareholderSell539$3.23$1,740.9725,833View SEC Filing Icon  
10/27/2023Zachary RomeDirectorSell958$3.06$2,931.4816,317View SEC Filing Icon  
8/30/2023Howard J WeismanCEOSell1,325$7.65$10,136.2538,682View SEC Filing Icon  
8/30/2023Zachary RomeDirectorSell282$7.99$2,253.1817,275View SEC Filing Icon  
8/28/2023Howard J WeismanCEOSell705$8.33$5,872.6540,572View SEC Filing Icon  
8/28/2023John F CoelhoDirectorSell45$8.84$397.804,687View SEC Filing Icon  
8/28/2023Michael DerbyMajor ShareholderSell411$8.33$3,423.6326,758View SEC Filing Icon  
8/21/2023Zachary RomeDirectorSell1,176$9.86$11,595.3620,546View SEC Filing Icon  
3/9/2023Karen LarochelleDirectorSell19$25.16$478.042,495View SEC Filing Icon  
3/9/2023Michael DerbyChairmanSell126$24.31$3,063.0619,084View SEC Filing Icon  
3/8/2023Howard J WeismanCEOSell1,905$24.82$47,282.1032,066View SEC Filing Icon  
3/8/2023Zachary RomeCOOSell1,766$24.99$44,132.3417,166View SEC Filing Icon  
3/6/2023Howard J WeismanCEOSell799$29.24$23,362.7635,357View SEC Filing Icon  
3/6/2023Michael DerbyChairmanSell813$29.24$23,772.1220,100View SEC Filing Icon  
3/6/2023Zachary RomeCOOSell797$29.24$23,304.2820,311View SEC Filing Icon  
3/2/2023Howard J WeismanCEOSell687$32.98$22,657.2637,058View SEC Filing Icon  
3/2/2023John F CoelhoDirectorSell177$32.81$5,807.373,962View SEC Filing Icon  
3/2/2023Michael DerbyChairmanSell617$32.98$20,348.6622,029View SEC Filing Icon  
3/2/2023Zachary RomeCOOSell761$32.98$25,097.7821,885View SEC Filing Icon  
See Full Table
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Full details and steps to take here.

SEC Filings (Institutional Ownership Changes) for PaxMedica (NASDAQ:PXMD)

1.28% of PaxMedica stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at PXMD by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

PaxMedica Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/26/2024Virtu Financial LLC56,441$43K0.0%N/A2.465%Search for SEC Filing on Google Icon
8/15/2023Citadel Advisors LLC68,991$54K0.0%N/A0.420%Search for SEC Filing on Google Icon
5/16/2023Susquehanna International Group LLP13,678$26K0.0%N/A0.101%Search for SEC Filing on Google Icon
5/16/2023Geode Capital Management LLC30,781$59K0.0%N/A0.227%Search for SEC Filing on Google Icon
5/12/2023UBS Group AG17,735$34K0.0%-46.9%0.131%Search for SEC Filing on Google Icon
2/10/2023Bank of America Corp DE14,546$30K0.0%N/A0.121%Search for SEC Filing on Google Icon
2/8/2023UBS Group AG33,404$68K0.0%+438.3%0.278%Search for SEC Filing on Google Icon
11/16/2022Jane Street Group LLC18,025$43K0.0%N/A0.153%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
PaxMedica logo
PaxMedica, Inc., a clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies for the treatment of disorders with intractable neurologic symptoms. The company's lead product candidate is PAX-101, an intravenous formulation of suramin for the treatment of autism spectrum disorder, myalgic encephalomyelitis/chronic fatigue syndrome, long COVID-19 syndrome, and human African trypanosomiasis (HAT). It also develops PAX-102, an intranasal formulation of suramin, as well as other new chemical entities that are targeted and selective antagonists of purine receptor subtypes; and PAX-HAT-301 for the treatment of HAT. The company was formerly known as Purinix Pharmaceuticals LLC and changed its name to PaxMedica, Inc. in April 2020. PaxMedica, Inc. was incorporated in 2018 and is based in Tarrytown, New York.
Read More on PaxMedica

Today's Range

Now: $0.63
Low: $0.63
High: $0.67

50 Day Range

MA: $0.60
Low: $0.41
High: $0.88

52 Week Range

Now: $0.63
Low: $0.37
High: $48.45


30,632 shs

Average Volume

152,663 shs

Market Capitalization

$1.44 million

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of PaxMedica?

PaxMedica's top insider shareholders include:
  1. Howard J Weisman (CEO)
  2. Michael Derby (Major Shareholder)
  3. Michael Derby (Chairman)
  4. Zachary Rome (COO)
  5. Zachary Rome (Director)
  6. John F Coelho (Director)
  7. Karen Larochelle (Director)
Learn More about top insider investors at PaxMedica.

Who are the major institutional investors of PaxMedica?

PaxMedica's top institutional investors include:
  1. Virtu Financial LLC — 2.46%
Learn More about top institutional investors of PaxMedica stock.

Which major investors are buying PaxMedica stock?

Within the previous quarter, PXMD stock was purchased by institutional investors including:
  1. Virtu Financial LLC